Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Global Price Controls Cost Rx Industry $18-$27 Bil. A Year, Commerce Says

Jan 03 2005

• By The Pink Sheet

Related Content

Reimportation Limits Remain In Medicare Agreement; HHS Study Requested

Nov 24 2003

Global Price Controls Elimination May Not Affect U.S. Rx Costs – Economist

Aug 09 2004

Canada-Only Import Plan “Feasible,” HHS Says: Savings Would Be “Modest”

Jan 03 2005

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window